The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Berenberg cuts target prices for miners

Tue, 09th Jan 2024 09:29

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Wednesday:

----------

FTSE 100

----------

Deutsche Bank raises Legal & General price target to 305 (295) pence - 'buy'

----------

Goldman Sachs raises Intermediate Capital price target to 1,920 (1,840) pence - 'buy'

----------

RBC raises Hikma Pharmaceuticals price target to 2,175 (2,150) pence - 'sector perform'

----------

Barclays raises Barratt Developments price target to 560 (464) pence - 'equal weight'

----------

Berenberg cuts Endeavour Mining price target to 2,000 (2,400) pence - 'buy'

----------

Berenberg raises Anglo American price target to 1,600 (1,500) pence - 'hold'

----------

Berenberg raises Rio Tinto price target to 6,200 (6,000) pence - 'buy'

----------

Jefferies cuts Rentokil Initial price target to 600 (650) pence - 'buy'

----------

Bernstein raises Diageo price target to 3,580 (3,465) pence - 'outperform'

----------

FTSE 250

----------

Barclays raises Bellway price target to 3,022 (2,330) pence - 'overweight'

----------

Berenberg raises Hochschild Mining price target to 140 (130) pence - 'buy'

----------

Jefferies cuts Drax Group price target to 660 (700) pence - 'buy'

----------

SMALL CAP

----------

Goldman Sachs raises Wise price target to 1,200 (1,150) pence - 'buy'

----------

Berenberg raises Yellow Cake price target to 744 (657) pence - 'buy'

----------

Berenberg cuts Wheaton Precious Metals price target to 4,500 (5,000) pence - 'buy'

----------

Berenberg cuts Tharisa price target to 130 (150) pence - 'buy'

----------

Berenberg cuts Sovereign Metals price target to 42 (90) pence - 'buy'

----------

Berenberg cuts Rainbow Rare Earths price target to 37 (38) pence - 'buy'

----------

Berenberg cuts Kenmare Resources price target to 480 (570) pence - 'hold'

----------

Berenberg raises Jubilee Metals price target to 10 (9) pence - 'buy'

----------

Berenberg cuts Greatland Gold price target to 12 (19) pence - 'buy'

----------

Berenberg cuts Ecora Resources price target to 150 (180) pence - 'buy'

----------

Berenberg cuts Central Asia Metals price target to 220 (240) pence - 'buy'

----------

Berenberg cuts BHP Group price target to 2,300 (2,400) pence - 'hold'

----------

Berenberg cuts Atalaya Mining price target to 370 (380) pence - 'hold'

----------

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
6 Aug 2021 12:07

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

LONDON MARKET MIDDAY: Caution dominates ahead of US nonfarm payrolls

Read more
6 Aug 2021 09:03

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

LONDON MARKET OPEN: Stocks soft, dollar up as US nonfarm payrolls near

Read more
6 Aug 2021 08:40

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

TOP NEWS: Hikma hikes Generics guidance as interim profit swells

Read more
6 Aug 2021 07:42

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

LONDON MARKET PRE-OPEN: LSEG raises Refinitiv cost synergy guidance

Read more
6 Aug 2021 07:22

Hikma lifts FY generics guidance as first-half profits, revenue jump

(Sharecast News) - Hikma Pharmaceuticals upgraded full-year guidance for its generics arm and reported a rise in first-half profit and revenue as it hailed a strong performance in both the generics and branded segments, and resilience in the injectables business.

Read more
30 Jul 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
14 Jul 2021 19:38

IN BRIEF: Arecor ends first half of 2021 with solid cash position

IN BRIEF: Arecor ends first half of 2021 with solid cash position

Read more
13 Jul 2021 10:00

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

BROKER RATINGS: Barclays upgrades Shell and EnQuest to Overweight

Read more
1 Jul 2021 09:51

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

BROKER RATINGS: Credit Suisse upgrades Legal & General and StanChart

Read more
21 Jun 2021 14:51

UPDATE 1-U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

(Adds background to case, paragraphs 4-10)By Blake BrittainWASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against gener...

Read more
21 Jun 2021 14:31

U.S. Supreme Court denies Amarin's bid to revive Vascepa drug patents

WASHINGTON, June 21 (Reuters) - The U.S. Supreme Court on Monday rejected a bid by an Amarin Corp PLC subsidiary to revive patents on its heart drug Vascepa in a legal battle against generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy's La...

Read more
8 Jun 2021 13:54

Tuesday broker round-up

(Sharecast News) - tinyBuild: Berenberg reiterates buy with a target price of 295p.

Read more
6 May 2021 09:46

BROKER RATINGS: Exane BNP downgrades three property companies

BROKER RATINGS: Exane BNP downgrades three property companies

Read more
30 Apr 2021 17:01

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

LONDON MARKET CLOSE: Stocks close out impressive April to end higher

Read more
30 Apr 2021 08:58

TOP NEWS: Hikma Pharma confident after promising start to year

TOP NEWS: Hikma Pharma confident after promising start to year

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.